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acknowledged as an important outcome in addition to oncologic outcomes and safety issues. [6] [7] [8] [9] In recent years, there has been significant progress in defining and measuring QOL in patients with gastric cancer and patients undergoing gastrectomy. 10 The European Organization for Research and Treatment of Cancer (EORTC) developed a cancerspecific questionnaire, the EORTC quality-of-life questionnaire (QLQ)-C30, which has good reliability and validity. [11] [12] [13] The EORTC QLQ-C30 evaluates the general condition of cancer patients. This questionnaire has been translated into 81 languages so far and has been used in more than 3,000 studies worldwide.
The EORTC QLQ-STO22 was developed to specifically evaluate the QOL of patients with gastric cancer and esophageal cancer. 14 The OG25 has different evaluation scales from the STO22 in terms of odynophagia, choked when swallowing, trouble talking, weight loss, trouble eating with others, trouble with swallowing saliva, and trouble with coughing. The aim of this study was to evaluate the accuracy of OG25 over the STO22 in assessing the QOL of patients who underwent gastrectomy, especially total gastrectomy.
Materials and Methods

Patients
In this prospective study, patients with gastric cancer in the Department of Surgery, Seoul National University Hospital were investigated from July 2014 to October 2015. Patients who were scheduled to undergo gastrectomy were included. A total of 182 patients were enrolled.
The patients were asked to fill out each questionnaire (STO22, OG25) 4 times: preoperatively, and at 3 weeks, 3 months, and 6 months after surgery by a tablet-PC based QOL assessment. The tablet-PC based QOL assessment system allows for changing the pattern display in the electronic medical record and an automatic height, body weight, and a body mass index (BMI) check system. At each visit, the patients checked their body weight.
The study was approved by the Institutional Review Board of the Seoul National University Hospital (1406-108-590), and informed consent was obtained from all participating patients.
Treatment details
A prospective analysis of the medical charts was performed considering, in particular, the age, sex, comorbidities, opera- 
Assessment of quality of life
The EORTC QLQ-STO22 includes 22 questions related to gastric cancer. The questionnaire items included five scales (dysphagia, chest and abdominal pain, reflux, eating restrictions, and anxieties) and four single items (dry mouth, body image, trouble with taste, and hair loss), reflecting disease symptoms, treatment side effects, and psychological issues. Higher scores indicated worse symptomatic problems. 15 The EORTC QLQ-OG25 is a 25-item module designed to increase the sensitivity and specificity of the QLQ-C30. This module comprises six multi-item scales: dysphagia, eating restrictions, reflux, odynophagia, pain, and anxiety, and 10 singleitem symptoms, with higher scores indicating worse symptomatic problems for both the multi-and single-item scales. whereas the PG group had a mean 6.52% decrease (P<0.001) at 3 weeks; 3 months after surgery, the TG group had a mean weight decrease of 11.7%, whereas the PG group had a mean weigh decrease of 7.53% (P<0.001).
Statistical analysis
Comparison of preoperative OG25 and STO22 scores
There were no significant differences in preoperative scores between the TG and PG groups on either the OG25 or STO22 (Table 2 ). There was also no significant difference in each individual score of either the OG25 or STO22 between the PG (n=122) and the TG (n=38) groups. Values are presented as mean scores. PG = partial gastrec tomy; TG = total gastrectomy. *Significant differences (P<0.05). Values are presented as mean scores. PG = partial gastrec tomy; TG = total gastrectomy.
Comparison of postoperative 3 weeks OG25 and STO22 scores
Scales discriminating total gastrectomy from partial gastrectomy on the OG25
The change in each of the scales according to time was analyzed. TG patients showed worse symptom scores including pain and discomfort, reflux, weight loss, dysphagia, anxiety, body image, eating, odynophagia, and trouble with taste symptoms than PG patients, as expected.
Only the OG25 can recognized the difference between the two groups for weight loss, odynophagia, choked when swallowing, and difficulty eating with others. The scores on these Values are presented as mean scores. PG = partial gastrec tomy; TG = total gastrectomy. *Significant differences (P<0.05). Values are presented as mean scores. PG = partial gastrec tomy; TG = total gastrectomy. *Significant differences (P<0.05).
scales changed over time and the changes were significantly different (Fig. 2) .
Discussion
In this study, the EORTC QLQ-STO22 and QLQ-OG25
were used to evaluate differences in the preoperatively and postoperatively reported outcomes between the TG and PG groups.
Worldwide, the incidence of esophageal cancer (EC) and gastric cardia cancer is increasing, whereas the incidence of noncardiac adenocarcinomas of the stomach is decreasing. 16, 17 The growing incidence of EC and gastric cardia cancer demonstrates the need for valid methods to measure health-related QOL in patients with esophagogastric junction cancer and proximal gastric cancer. 18 This study aimed to identify differences between the TG and PG groups during the pre-and postoperative periods using the EORTC QLQ-STO22 and QLQ-OG25, and to evaluate the QOL of gastrectomized patients. The study also examined changes in weight between the two groups over time to determine which group showed a significant weight change.
Although significant differences were not observed in reported symptoms between the two groups in the pre-operative period, significant differences did occur postoperatively.
In particular, 3 weeks after surgery, symptoms of pain and discomfort, reflux, weight loss, and dysphagia were worse in the TG group than in the PG group, as confirmed by the OG25.
The two items of pain/discomfort and weight loss could only be confirmed by the OG25, not the STO22. Likewise, body image, eating, odynophagia, odynophagia, trouble with taste, weight loss, and dysphagia were worse 3 months after surgery in the TG group than in the PG group. Among these symptoms, body image, odynophagia, trouble with taste, and weight loss could only be confirmed by the OG25. Similarly, 6 months after surgery, the symptoms of body image, eating, odynophagia, weight loss, and dysphagia were confirmed by the OG25 to be worse in the TG group than in the PG group. Among these symptoms, odynophagia and weight loss cannot be identified by the STO22.
Furthermore, differences in symptoms observed between groups over time were confirmed only by the OG25, which includes scales for odynophagia, weight loss, choked when swallowing, and trouble eating with others.
Six months after surgery, the TG group had a weight decrease of 12.71% whereas the PG group had a 7.35 % decrease (P<0.001).
Similar to our results, Kim et al. 19 showed that QOL of patients in the TG group was lower than that of patients in the PG group, reporting that QOL of patients in the TG group remained worse than that of the patients in the PG group, even after adjusting for cancer stage and other potential confounders. Their study found that QOL varies depending on the presence of the gastroesophageal junction (i.e., the upper third of the stomach) after surgery, which the OG25 accounts for better than the STO22. Similarly, Oñate-Ocaña et al. 20 items from the short form-8, 15 items from the Gastrointestinal Symptom Rating Scale, and an additional 22 items. 21 This study had the following limitations: first, it was a prospective cohort study at a single hospital, examining a small number of patients. Also, the patients' follow-up period was 6 months, which allowed the confirmation of short-term QOL only, not long-term QOL. In conclusion, the OG25 is a more sensitive and useful scale than the STO22 for the evaluation of QOL in gastrectomized patients, especially those with total gastrectomy.
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